Authors

• Rodolfo Javier Galindo (ORCID: https://orcid.org/0000-0002-9295-3225)
• Lance Alan Sloan (ORCID: https://orcid.org/0000-0001-7362-4410)
• Iulia Cristina Tudor (ORCID: https://orcid.org/0000-0002-4229-2940)
• Omar Al Dhaybi (ORCID: https://orcid.org/0000-0003-3748-2317)
• T. Iványi
• Pam R. Taub (ORCID: https://orcid.org/0000-0002-0684-0655)
• Luke J. Laffin (ORCID: https://orcid.org/0000-0002-3262-792X)
• Dianne S Cheung
• John C. Parker
• Florian Rader
• Jorge Plutzky
• Deepak L. Bhatt
• Ralph A. DeFronzo
• Robert S. Busch
• Julio Rosenstock
• Michael J. Bloch
• Jan N. Basile
• Daniel Einhorn
• Matthew Budoff
• Elena A. Christofides

Institutions

• University of North Carolina at Chapel Hill (US)
• Cedars-Sinai Medical Center (US)
• Brigham and Women's Hospital (US)
• Cleveland Clinic (US)
• University of Nevada, Reno (US)
• University of Miami (US)
• Medical University of South Carolina (US)
• University of North Carolina Wilmington (US)
• University of California, Los Angeles (US)
• The University of Texas at San Antonio Health Science Center (US)
• Lankenau Institute for Medical Research (US)
• Wilmington University (US)
• Medical City Dallas Hospital (US)
• Renown Health (US)
• University of California San Diego (US)
• Columbus Oncology and Hematology Associates (US)
• Mount Sinai Hospital (US)
• Tarzana Treatment Centers (US)
• Corcept Therapeutics (United States) (US)
• Velocity Clinical Research (United States) (US)
• Harbor–UCLA Medical Center (US)
• Albany Medical Center Hospital (US)

Publication Details

Journal

JACC Advances

Published

2026-02-16

DOI

https://doi.org/10.1016/j.jacadv.2026.102596

Primary Topic

Pituitary Gland Disorders and Treatments

Type

article

Field-Weighted Citation Impact

0.00